Bide Pharmatech Co. Ltd. A (SHG:688073) — Market Cap & Net Worth
Market Cap & Net Worth: Bide Pharmatech Co. Ltd. A (688073)
Bide Pharmatech Co. Ltd. A (SHG:688073) has a market capitalization of $1.01 Billion (CN¥6.92 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #8935 globally and #2204 in its home market, demonstrating a 26.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bide Pharmatech Co. Ltd. A's stock price CN¥76.10 by its total outstanding shares 90882948 (90.88 Million). Also see 688073 total assets for a full breakdown of the balance sheet.
Bide Pharmatech Co. Ltd. A Market Cap History: 2022 to 2026
Bide Pharmatech Co. Ltd. A's market capitalization history from 2022 to 2026. Data shows growth from $744.83 Million to $1.01 Billion (13.62% CAGR). Also see 688073 cash flow metrics for how efficiently the company converts equity into cash flow.
Bide Pharmatech Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bide Pharmatech Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Bide Pharmatech Co. Ltd. A (688073) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.61x
Bide Pharmatech Co. Ltd. A's market cap is 0.61 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.35x
Bide Pharmatech Co. Ltd. A's market cap is 5.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $744.83 Million | $833.83 Million | $145.97 Million | 0.89x | 5.10x |
| 2023 | $716.47 Million | $1.09 Billion | $109.57 Million | 0.66x | 6.54x |
| 2024 | $653.78 Million | $1.10 Billion | $117.43 Million | 0.59x | 5.57x |
| 2025 | $811.91 Million | $1.32 Billion | $151.74 Million | 0.61x | 5.35x |
Competitor Companies of 688073 by Market Capitalization
Companies near Bide Pharmatech Co. Ltd. A in the global market cap rankings as of September 24, 2026. Review 688073 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Bide Pharmatech Co. Ltd. A by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
Bide Pharmatech Co. Ltd. A Historical Marketcap From 2022 to 2026
Between 2022 and today, Bide Pharmatech Co. Ltd. A's market cap moved from $744.83 Million to $ 1.01 Billion, with a yearly change of 13.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.01 Billion | +24.65% |
| 2025 | CN¥811.91 Million | +24.19% |
| 2024 | CN¥653.78 Million | -8.75% |
| 2023 | CN¥716.47 Million | -3.81% |
| 2022 | CN¥744.83 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Bide Pharmatech Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.01 Billion USD |
| MoneyControl | $1.01 Billion USD |
| MarketWatch | $1.01 Billion USD |
| marketcap.company | $1.01 Billion USD |
| Reuters | $1.01 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bide Pharmatech Co. Ltd. A
Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. Its products are used in life sciences, organic chemistry, analytical chemistry, and other applications. The company was founded in 2007 and is based in Shanghai, China.